Global Plasma Protein Therapeutics Market to Reach $38.4 Billion by 2030
The global market for Plasma Protein Therapeutics estimated at US$27.7 Billion in the year 2023, is expected to reach US$38.4 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Albumin, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$8.6 Billion by the end of the analysis period. Growth in the Plasma Derived Factor VIII segment is estimated at 3.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $8.4 Billion, While China is Forecast to Grow at 4.6% CAGR
The Plasma Protein Therapeutics market in the U.S. is estimated at US$8.4 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.8 Billion by the year 2030 trailing a CAGR of 4.6% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 4% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook